XML 111 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Segment and Geographic Information
9 Months Ended
Jan. 24, 2020
Segment Reporting [Abstract]  
Segment and Geographic Information Segment and Geographic Information
Segment disclosures are on a performance basis consistent with internal management reporting. Net sales of the Company's reportable segments include end-customer revenues from the sale of products the segment develops, manufactures, and distributes. There are certain corporate and centralized expenses that are not allocated to the segments.
The Company’s management evaluates performance of the segments and allocates resources based on segment operating profit. Segment operating profit represents income before income taxes, excluding interest expense, amortization of intangible assets, centralized distribution costs, non-operating income or expense items, certain corporate charges, and other items not allocated
to the segments. The financial information that is regularly reviewed by the Company's chief operating decision maker to assess performance and allocate resources changed during the first quarter of fiscal year 2020 to remove the impact of non-service pension and post-retirement benefit costs from segment results. This change did not have a material impact on the segment results reviewed. As a result of the change, the Company has revised the disclosure for the prior period to align with the current presentation.
The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies in Note 1 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended April 26, 2019. Certain depreciable assets may be recorded by one segment, while the depreciation expense is allocated to another segment. The allocation of depreciation expense is based on the proportion of the assets used by each segment.
The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:
Net Sales
 
Three months ended (1)
Nine months ended (1)
(in millions)January 24, 2020January 25, 2019January 24, 2020January 25, 2019
Cardiac and Vascular Group$2,819  $2,786  $8,464  $8,455  
Minimally Invasive Therapies Group2,176  2,124  6,418  6,223  
Restorative Therapies Group2,111  2,026  6,235  5,968  
Diabetes Group610  610  1,798  1,765  
Total$7,717  $7,546  $22,916  $22,411  
(1) The data in this schedule has been intentionally rounded to the nearest million and, therefore, may not sum.
Segment Operating Profit
 Three months endedNine months ended
(in millions)January 24, 2020January 25, 2019January 24, 2020January 25, 2019
Cardiac and Vascular Group$1,101  $1,076  $3,284  $3,262  
Minimally Invasive Therapies Group860  828  2,453  2,396  
Restorative Therapies Group898  824  2,531  2,394  
Diabetes Group158  190  456  538  
Segment operating profit3,017  2,918  8,724  8,590  
Interest expense(156) (243) (930) (726) 
Other non-operating income, net96  71  305  309  
Amortization of intangible assets(436) (436) (1,317) (1,327) 
Corporate(348) (331) (1,005) (974) 
Centralized distribution costs(348) (383) (1,117) (1,313) 
Restructuring and associated costs(97) (66) (315) (256) 
Acquisition-related items(28) (17) (74) (57) 
Certain litigation charges(108) (63) (276) (166) 
IPR&D charges—  (11) —  (26) 
Exit of businesses—  (69) (41) (149) 
Debt tender premium and other charges—  —   —  
Medical device regulations(13) —  (31) —  
Contribution to Medtronic Foundation—  —  (80) —  
Income before income taxes$1,579  $1,370  $3,850  $3,905  
Geographic Information
Net sales are attributed to the country based on the location of the customer taking possession of the products or in which the services are rendered. The following table presents net sales for the three and nine months ended January 24, 2020 and January 25, 2019 for the Company's country of domicile, countries with significant concentrations, and all other countries: 
 Three months ended Nine months ended
(in millions)January 24, 2020January 25, 2019January 24, 2020January 25, 2019
Ireland$22  $24  $66  $68  
United States 4,021  4,001  12,068  11,910  
Rest of world3,674  3,521  10,782  10,433  
Total other countries, excluding Ireland7,695  7,522  22,850  22,343  
Total$7,717  $7,546  $22,916  $22,411